18F-FDG PET/CT can be used to predict progression in smoldering multiple myeloma patients

被引：0
|
作者：
Visram, Alissa [1 ]
Rajkumar, Vincent [2 ]
Kumar, Shaji [3 ]
Broski, Stephen [2 ]
机构：
[1] Ottawa Hosp, Ottawa, ON, Canada
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin Rochester, Dept Hematol, Rochester, MN USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-180
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [1] 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
    Zamagni, E.
    Nanni, C.
    Gay, F.
    Pezzi, A.
    Patriarca, F.
    Bello, M.
    Rambaldi, I.
    Tacchetti, P.
    Hillengass, J.
    Gamberi, B.
    Pantani, L.
    Magarotto, V.
    Versari, A.
    Offidani, M.
    Zannetti, B.
    Carobolante, F.
    Balma, M.
    Musto, P.
    Rensi, M.
    Mancuso, K.
    Dimitrakopoulou-Strauss, A.
    Chauvie, S.
    Rocchi, S.
    Fard, N.
    Marzocchi, G.
    Storto, G.
    Ghedini, P.
    Palumbo, A.
    Fanti, S.
    Cavo, M.
    [J]. LEUKEMIA, 2016, 30 (02) : 417 - 422
  • [2] 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
    E Zamagni
    C Nanni
    F Gay
    A Pezzi
    F Patriarca
    M Bellò
    I Rambaldi
    P Tacchetti
    J Hillengass
    B Gamberi
    L Pantani
    V Magarotto
    A Versari
    M Offidani
    B Zannetti
    F Carobolante
    M Balma
    P Musto
    M Rensi
    K Mancuso
    A Dimitrakopoulou-Strauss
    S Chauviè
    S Rocchi
    N Fard
    G Marzocchi
    G Storto
    P Ghedini
    A Palumbo
    S Fanti
    M Cavo
    [J]. Leukemia, 2016, 30 : 417 - 422
  • [3] Role of 18F-FDG PET-CT and MRI in diagnosis of smoldering multiple myeloma and plasmocytoma
    Mestre Fusco, A.
    Senin, A.
    Abella, E.
    Garcia-Pallarols, F.
    Ares, J.
    Solano, A.
    Suarez-Pinera, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S318 - S319
  • [4] ROLE OF 18 F-FDG PET/CT IN THE ASSESSMENT OF PATIENTS WITH SMOLDERING MULTIPLE MYELOMA
    Za, T.
    Rossi, E.
    Caldarella, C.
    Ciminello, A.
    Betti, S.
    Fianchi, L.
    Rufini, V.
    Leone, G.
    Giordano, A.
    De Stefano, V.
    [J]. HAEMATOLOGICA, 2013, 98 : 596 - 596
  • [5] Role of 18F-FDG PET/CT in staging of patients with multiple myeloma
    Zhao, Jun
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [6] 18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma
    Albano, Domenico
    Bosio, Giovanni
    Treglia, Giorgio
    Giubbini, Raffaele
    Bertagna, Francesco
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (01) : 77 - 84
  • [7] Can 18F-FDG PET/CT findings be used to predict orbital tumor histology?
    Monjanel, B.
    Nivaggioni, G.
    Staccini, P.
    Gastaud, L.
    Lassalle, S.
    Baillif, S.
    Tieulie, N.
    Martel, A.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2024, 47 (01):
  • [8] The value of 18F-FDG PET/CT in the diagnosis of multiple myeloma
    Niu, Xiaobo
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S486 - S487
  • [9] Prognostic value of 18F-FDG PET/CT in patients with relapsed multiple myeloma
    Guo, Yue-Hong
    Liu, Ai-Jun
    Huang, Jing-Wei
    Wang, Li
    Yang, Min-Fu
    [J]. ANNALS OF HEMATOLOGY, 2024,
  • [10] 18F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment
    Jung, Sung-Hoon
    Moon, Joon Ho
    Back, Dong Won
    Ahn, Seo-Yeon
    Yang, Deok-Hwan
    Ahn, Jae-Sook
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E189 - E190
12345